These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3158006

  • 21. Influence of acetylsalicylic acid (1.0 g/day) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease.
    Minar E, Ehringer H.
    Thromb Res; 1987 Mar 15; 45(6):791-802. PubMed ID: 2954264
    [Abstract] [Full Text] [Related]

  • 22. Acetylsalicylic acid differentially limits the activation and expression of cell death markers in human platelets exposed to Staphylococcus aureus strains.
    Chabert A, Damien P, Verhoeven PO, Grattard F, Berthelot P, Zeni F, Panicot-Dubois L, Robert S, Dignat-George F, Eyraud MA, Pozzetto B, Payrastre B, Cognasse F, Garraud O, Hamzeh-Cognasse H.
    Sci Rep; 2017 Jul 17; 7(1):5610. PubMed ID: 28717145
    [Abstract] [Full Text] [Related]

  • 23. Beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) release by adenosine diphosphate (ADP) contact with native whole blood.
    Pengo V, Boschello M, Prandoni P, Schivazappa L, Girolami A.
    Thromb Res; 1985 Sep 01; 39(5):645-50. PubMed ID: 2417360
    [No Abstract] [Full Text] [Related]

  • 24. Two distinct mechanisms of inhibition of platelets aggregation by acetylsalicylic acid.
    Ferri A, Calza R, Pellegrini A, Cattani L.
    Biochem Mol Biol Int; 1994 Apr 01; 32(6):1101-7. PubMed ID: 8061627
    [Abstract] [Full Text] [Related]

  • 25. The effects of bupivacaine and pipecoloxylidide on platelet function in vitro.
    Odoom JA, Sturk A, Dokter PW, Bovill JG, ten Cate JW, Oosting J.
    Acta Anaesthesiol Scand; 1989 Jul 01; 33(5):385-8. PubMed ID: 2529732
    [Abstract] [Full Text] [Related]

  • 26. [Lack of effect of low dose acetylsalicylic acid (100 mg/die) on thrombocyte survival and beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4) in patients with peripheral arterial occlusive disease].
    Minar E, Ehringer H, Jung M, Koppensteiner R, Stümpflen A, Ahmadi R.
    Vasa Suppl; 1989 Jul 01; 27():244-6. PubMed ID: 2533741
    [No Abstract] [Full Text] [Related]

  • 27. [Effects of 2 doses of lysine acetylsalicylate on platelet aggregation, beta-thromboglobulin and platelet factor 4 in aged atherosclerotic patients].
    Roussel B, Delobel J, Sangosse J, Dieval J, Claisse JF, Lienard J.
    Therapie; 1988 Jul 01; 43(4):267-71. PubMed ID: 2973148
    [No Abstract] [Full Text] [Related]

  • 28. Cloricromene inhibits the activation of human platelets by ADP alone or in combination with adrenaline.
    Del Maschio A, Bazzoni G, Zatta A, Chen ZM, Dejana E, Prosdocimi M.
    Eur J Pharmacol; 1990 Oct 23; 187(3):541-5. PubMed ID: 2073928
    [Abstract] [Full Text] [Related]

  • 29. Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
    Prosdocimi M, Finesso M, Tessari F, Gorio A, Languino LR, de Gaetano G, Dejana E.
    Thromb Res; 1985 Aug 15; 39(4):399-409. PubMed ID: 3840290
    [Abstract] [Full Text] [Related]

  • 30. Dipyridamole specifically decreases platelet-derived growth factor release from platelets.
    Takehara K, Igarashi A, Ishibashi Y.
    Thromb Res Suppl; 1990 Aug 15; 12():73-9. PubMed ID: 2150573
    [Abstract] [Full Text] [Related]

  • 31. Methods for the detection of activated platelets.
    Pareti FI, D'Angelo A, Mannucci PM.
    Adv Exp Med Biol; 1984 Aug 15; 164():155-66. PubMed ID: 6229978
    [No Abstract] [Full Text] [Related]

  • 32. Effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonylme tho xy coumarin) on cyclic nucleotide phosphodiesterases in human platelets.
    Hakim G, Fiorentini D, Falasca A, Prosdocimi M, Rossi CA.
    Experientia; 1988 Mar 15; 44(3):226-8. PubMed ID: 2832208
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo. Randomized, double-blind cross-over study.
    Ikeda Y, Kikuchi M, Murakami H, Satoh K, Murata M, Watanabe K, Ando Y.
    Arzneimittelforschung; 1987 May 15; 37(5):563-6. PubMed ID: 2956957
    [Abstract] [Full Text] [Related]

  • 34. Increased platelet-derived mitogenic activity in plasma of young patients with coronary atherosclerosis.
    Nilsson J, Svensson J, Hamsten A, de Faire U.
    Atherosclerosis; 1986 Sep 15; 61(3):237-43. PubMed ID: 2429675
    [Abstract] [Full Text] [Related]

  • 35. Ticlopidine activity on platelet function in patients with enhanced platelet aggregation. A short-term crossover study.
    Gensini GF, Favilla S, Breschi C, Abbate R, Costanzo G, Neri Serneri GG.
    Haemostasis; 1983 Sep 15; 13(5):294-300. PubMed ID: 6228500
    [Abstract] [Full Text] [Related]

  • 36. Effect of labetalol on human platelet function.
    Anfossi G, Trovati M, Lanzio M, Mularoni E, Massucco P, Emanuelli G.
    Clin Exp Pharmacol Physiol; 1988 Jun 15; 15(6):437-48. PubMed ID: 2856060
    [Abstract] [Full Text] [Related]

  • 37. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alpha-granules or lysosomes from, human platelets.
    Chronos NA, Wilson DJ, Janes SL, Hutton RA, Buller NP, Goodall AH.
    Clin Sci (Lond); 1994 Nov 15; 87(5):575-80. PubMed ID: 7533066
    [Abstract] [Full Text] [Related]

  • 38. Aspirin at therapeutic concentrations does not affect 5-hydroxytryptamine uptake by platelets.
    Drummond AH, MacIntyre DE, Olverman HJ.
    Br J Pharmacol; 1977 Apr 15; 59(4):661-2. PubMed ID: 858010
    [Abstract] [Full Text] [Related]

  • 39. Prevention of the platelet alpha-granule release reaction by membrane-active drugs.
    Prowse C, Pepper D, Dawes J.
    Thromb Res; 1982 Feb 01; 25(3):219-27. PubMed ID: 6175045
    [Abstract] [Full Text] [Related]

  • 40. Platelet aggregation and adhesiveness as well as blood lipids level in dogs treated with di-(1-isoquinolinyl)-di-(pyridyl-2')-butane and carbocromen.
    Woyke M, Cwajda H, Wójcicki J.
    Pol J Pharmacol Pharm; 1978 Feb 01; 30(1):77-81. PubMed ID: 643741
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.